Pak‐Hei Chan

791 total citations
18 papers, 506 citations indexed

About

Pak‐Hei Chan is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Internal Medicine. According to data from OpenAlex, Pak‐Hei Chan has authored 18 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 4 papers in Epidemiology and 3 papers in Internal Medicine. Recurrent topics in Pak‐Hei Chan's work include Atrial Fibrillation Management and Outcomes (14 papers), Cardiac Arrhythmias and Treatments (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Pak‐Hei Chan is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Cardiac Arrhythmias and Treatments (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Pak‐Hei Chan collaborates with scholars based in Hong Kong, China and United Kingdom. Pak‐Hei Chan's co-authors include Chung‐Wah Siu, Chun‐Ka Wong, Daniel Wai‐Sing Chu, Ming‐Zher Poh, Yukkee C. Poh, Hung‐Fat Tse, Gregory Y.H. Lip, Duo Huang, Ian Chi Kei Wong and Jo Jo Hai and has published in prestigious journals such as PLoS ONE, Heart and Medicine.

In The Last Decade

Pak‐Hei Chan

18 papers receiving 488 citations

Peers

Pak‐Hei Chan

CCM

EPIDE

SURGE

Donald D. Hoang United States

Agostino Piro Italy

Alexander Samol Germany

Søren Pihlkjær Hjortshøj Denmark

Niccolò Bonini Italy

Francis Morris United Kingdom

Guy Rozen United States

Mika Niemelä Finland

Máximo Rivero‐Ayerza Belgium

Benoit Coutu Canada

Donald D. Hoang United States

Pak‐Hei Chan

544 ×1.2

CCM

40 ×0.5

75 ×1.0

43 ×0.7

EPIDE

46 ×0.9

SURGE

Citations per year, relative to Pak‐Hei Chan Pak‐Hei Chan (= 1×) peers Donald D. Hoang

Countries citing papers authored by Pak‐Hei Chan

Since Specialization

Citations

This map shows the geographic impact of Pak‐Hei Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pak‐Hei Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pak‐Hei Chan more than expected).

Fields of papers citing papers by Pak‐Hei Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pak‐Hei Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pak‐Hei Chan. The network helps show where Pak‐Hei Chan may publish in the future.

Co-authorship network of co-authors of Pak‐Hei Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Pak‐Hei Chan. A scholar is included among the top collaborators of Pak‐Hei Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pak‐Hei Chan. Pak‐Hei Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Huang, Duo, Chun‐Ka Wong, Mingliang Zuo, et al.. (2019). Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study. Blood Research. 54(3). 175–180. 14 indexed citations

Poh, Ming‐Zher, Yukkee C. Poh, Pak‐Hei Chan, et al.. (2018). Diagnostic assessment of a deep learning system for detecting atrial fibrillation in pulse waveforms. Heart. 104(23). 1921–1928. 84 indexed citations

Huang, Duo, Pak‐Hei Chan, Wensheng Yue, et al.. (2018). Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin. Postgraduate Medical Journal. 94(1110). 207–211. 2 indexed citations

Wong, Chun‐Ka, et al.. (2017). WATCHMAN device-related thrombus successfully treated with apixaban. Medicine. 96(47). e8693–e8693. 5 indexed citations

Chan, Pak‐Hei, et al.. (2017). Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting. BMJ Open. 7(6). e013685–e013685. 41 indexed citations

Fang, Jonathan, et al.. (2017). Extrinsic pulmonary artery compression mimicking acute pulmonary embolism. Clinical Case Reports. 5(10). 1591–1593. 1 indexed citations

Hai, Jo Jo, Pak‐Hei Chan, Yap‐Hang Chan, et al.. (2016). Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry. PLoS ONE. 11(12). e0169095–e0169095. 7 indexed citations

Chan, Pak‐Hei, Chu‐Pak Lau, Hung‐Fat Tse, Chern‐En Chiang, & Chung‐Wah Siu. (2016). CHA 2 DS 2 -VASc Recalibration With an Additional Age Category (50-64 Years) Enhances Stroke Risk Stratification in Chinese Patients With Atrial Fibrillation. Canadian Journal of Cardiology. 32(12). 1381–1387. 15 indexed citations

Chan, Pak‐Hei, Duo Huang, Chu‐Pak Lau, et al.. (2016). Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA2DS2-VASc and Time in Therapeutic Range. Canadian Journal of Cardiology. 32(10). 1247.e15–1247.e21. 13 indexed citations

10.

Hai, Jo Jo, Chun‐Ka Wong, Pak‐Hei Chan, et al.. (2016). Quinidine for Brugada syndrome: Panacea or poison?. HeartRhythm Case Reports. 2(6). 486–490. 1 indexed citations

11.

Chan, Pak‐Hei, Chun‐Ka Wong, Yukkee C. Poh, et al.. (2016). Diagnostic Performance of a Smartphone‐Based Photoplethysmographic Application for Atrial Fibrillation Screening in a Primary Care Setting. Journal of the American Heart Association. 5(7). 170 indexed citations

12.

Chan, Pak‐Hei, Jo Jo Hai, Duo Huang, et al.. (2016). Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention. SAGE Open Medicine. 4. 2103734414–2103734414. 5 indexed citations

13.

Li, Wenhua, Duo Huang, Chern‐En Chiang, et al.. (2016). Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project. Clinical Cardiology. 40(4). 222–229. 42 indexed citations

14.

Chan, Pak‐Hei, Wenhua Li, Jo Jo Hai, et al.. (2015). Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation. Canadian Journal of Cardiology. 32(10). 1247.e23–1247.e28. 24 indexed citations

15.

Chan, Pak‐Hei, Wenhua Li, Jo Jo Hai, et al.. (2015). Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control. European Heart Journal - Cardiovascular Pharmacotherapy. 1(4). 265–272. 10 indexed citations

16.

Chan, Pak‐Hei, Duo Huang, Jo Jo Hai, et al.. (2015). Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. EP Europace. 18(5). 665.1–671. 38 indexed citations

17.

Lau, Kui Kai, Pak‐Hei Chan, Kai‐Hang Yiu, et al.. (2014). Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke. Cardiology Journal. 21(5). 474–483. 32 indexed citations

18.

Chan, Pak‐Hei, Shasha Liu, Hung‐Fat Tse, et al.. (2013). Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients.. PubMed. 10(4). 330–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact